Final Glance: Biotechnology companies
AP - Thu Oct 16, 5:02PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
GILD: 96.88 (+0.72), AMGN: 130.45 (-0.45), CELG: 86.38 (-0.17)
Agios (AGIO) Rises on Expansion of Phase I Study on AG-221 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 3:10PM CDT
Agios Pharmaceuticals (AGIO) initiated four expansion cohorts in its ongoing phase I study on AG-221.
MDVN: 92.54 (+2.91), EBS: 21.24 (+0.35), AGIO: 64.93 (-0.30), CELG: 86.38 (-0.17)
Midday Glance: Biotechnology companies
AP - Thu Oct 16, 12:21PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 96.88 (+0.72), AMGN: 130.45 (-0.45), CELG: 86.38 (-0.17)
Early Glance: Biotechnology companies
AP - Thu Oct 16, 10:35AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 10 a.m.:
GILD: 96.88 (+0.72), AMGN: 130.45 (-0.45), CELG: 86.38 (-0.17)
A Quick Look at Celgene Corporation's Drug Development Pipeline
Sean Williams, The Motley Fool - Motley Fool - Thu Oct 16, 8:35AM CDT
Source: Dr. Wendy Longo via Flickr . We're taught, as investors, to keep our eyes on the future because the stock market rarely gives much credence to what a business has done in the past. This couldn't be truer when it comes to the...
XLRN: 29.05 (-0.09), CELG: 86.38 (-0.17)
Was Celgene's Crohn's Disease Drug Worth The Price?
at Investor's Business Daily - Wed Oct 15, 4:39PM CDT
Big-cap biotech Celgene made its name as a cancer fighter, but now it's branching out into diseases of the immune system. And one of the biggest tests of this new strategy comes this weekend. At the United European Gastroenterology Week in Vienna,...
JNJ: 96.78 (-1.43), ABBV: 52.90 (-1.73), CELG: 86.38 (-0.17)
Technical Scrutiny on Health Care Sector Stocks - ImmunoGen, Arrowhead Research, Chimerix, Tekmira Pharma, and Celgene
PR Newswire - Wed Oct 15, 8:10AM CDT
Investor-Edge has initiated coverage on the following equities: ImmunoGen Inc. (NASDAQ: IMGN), Arrowhead Research Corporation (NASDAQ: ARWR), Chimerix Inc. (NASDAQ: CMRX), Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR), and Celgene Corporation (NASDAQ: CELG). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Tuesday, October 14, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 16,315.19, down 0.04% and the NASDAQ Composite closed at 4,227.17, up 0.32%. The S&P 500 finished the session 0.16% higher at 1,877.70. During the trading session, six out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 705.81, down 0.76%, whereas the index has advanced 9.89% on YTD basis. Register for your complimentary reports on these five stocks at:
CMRX: 35.40 (+3.22), ARWR: 7.02 (+0.55), IMGN: 8.38 (-0.38), TKMR: 22.81 (-1.09), CELG: 86.38 (-0.17)
Celgene Set to Possibly Rebound After Yesterday's Selloff of 1.14%
Comtex SmarTrend(R) - Tue Oct 14, 3:43PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $85.62 to a high of $88.99. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $86.55 on volume of 6.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CELG: 86.38 (-0.17)
After Yesterday's Decline of 1.14%, Celgene Offers Investors Better Value
Comtex SmarTrend(R) - Tue Oct 14, 3:43PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $85.62 to a high of $88.99. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $86.55 on volume of 6.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CELG: 86.38 (-0.17)
Where Will Celgene Corporation Stock Be a Year From Now?
Motley Fool Staff - Motley Fool - Tue Oct 14, 11:20AM CDT
Source: Celgene. The markets have gotten a little panicky lately, so last week we asked some of our top analysts to tell us what they think are the best companies to buy in a time of tumbling ticker tape . One pick was Celgene , a biotech...
JNJ: 96.78 (-1.43), PFE: 27.70 (-0.49), AMGN: 130.45 (-0.45), CELG: 86.38 (-0.17)
Acquisition, Market Activity, and Upcoming Events - Research Reports on Auxilium, Lakeland, Endo, Actavis and Celgene
PR Newswire - Tue Oct 14, 7:30AM CDT
Today, Analysts Review released its research reports regarding Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL), Lakeland Industries Inc. (NASDAQ: LAKE), Endo International plc (NASDAQ: ENDP), Actavis plc (NYSE: ACT) and Celgene Corporation (NASDAQ: CELG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7148-100free.
ENDP: 60.59 (+0.40), ACT: 222.07 (+4.83), QLTI: 3.99 (+0.03), AUXL: 30.35 (-0.06), LAKE: 20.69 (-2.91), CELG: 86.38 (-0.17), CELGZ: 3.61 (+0.09)
Apple, McKesson Among Big Caps In Trading Range
at Investor's Business Daily - Mon Oct 13, 5:38PM CDT
Many leading stocks have been forming flat bases as the market undergoes a series of fairly shallow pullbacks. In a flat base, a stock corrects 15% or less, with the ideal buy point typically 10 cents above the high of the left side. Leaders holding...
MCK: 185.32 (+0.30), GILD: 96.88 (+0.72), AAPL: 96.26 (-1.28), REGN: 340.71 (+5.96), CELG: 86.38 (-0.17)
Celgene's Otezla Encourages in Plaque Psoriasis at EADV - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 4:19PM CDT
Celgene (CELG) presented positive data on Otezla at the EADV.
MDVN: 92.54 (+2.91), SHPG: 178.46 (+7.97), REGN: 340.71 (+5.96), CELG: 86.38 (-0.17)
Cheap Stocks Wall Street Loves: Celgene Corporation
Selena Maranjian, The Motley Fool - Motley Fool - Mon Oct 13, 8:00AM CDT
Photo: Celgene Corporation. When looking for promising candidates for your portfolio, it makes sense to seek out undervalued, or cheap, stocks. Analysts on Wall Street do the same, and they slap ratings on thousands of stocks. Ratings are positive...
CELG: 86.38 (-0.17)
SmarTrend Watching for Potential Rebound in Shares of Celgene After 1.58% Loss
Comtex SmarTrend(R) - Fri Oct 10, 4:52PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $90.87 to a high of $93.85. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $91.54 on volume of 4.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CELG: 86.38 (-0.17)